214 related articles for article (PubMed ID: 19160227)
1. WITHDRAWN: Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; Deakin M; Philip S
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003890. PubMed ID: 19160227
[TBL] [Abstract][Full Text] [Related]
2. Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
Cochrane Database Syst Rev; 2004; (3):CD003890. PubMed ID: 15266506
[TBL] [Abstract][Full Text] [Related]
3. Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
6. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
[TBL] [Abstract][Full Text] [Related]
7. Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus.
Colunga-Lozano LE; Gonzalez Torres FJ; Delgado-Figueroa N; Gonzalez-Padilla DA; Hernandez AV; Roman Y; Cuello-GarcÃa CA
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011296. PubMed ID: 30488948
[TBL] [Abstract][Full Text] [Related]
8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
9. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.
Vos RC; van Avendonk MJ; Jansen H; Goudswaard AN; van den Donk M; Gorter K; Kerssen A; Rutten GE
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006992. PubMed ID: 27640062
[TBL] [Abstract][Full Text] [Related]
10. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
Cochrane Database Syst Rev; 2004 Oct; (4):CD003287. PubMed ID: 15495047
[TBL] [Abstract][Full Text] [Related]
11. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
Cochrane Database Syst Rev; 2004; (2):CD003287. PubMed ID: 15106199
[TBL] [Abstract][Full Text] [Related]
12. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
[TBL] [Abstract][Full Text] [Related]
13. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
14. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
15. Different insulin types and regimens for pregnant women with pre-existing diabetes.
O'Neill SM; Kenny LC; Khashan AS; West HM; Smyth RM; Kearney PM
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011880. PubMed ID: 28156005
[TBL] [Abstract][Full Text] [Related]
16. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
[TBL] [Abstract][Full Text] [Related]
18. Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.
Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Gerlach FM
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013228. PubMed ID: 30556900
[TBL] [Abstract][Full Text] [Related]
19. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
[TBL] [Abstract][Full Text] [Related]
20. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]